Suchergebnisse - "Boloko, Linda"

PubPharm (13)

1

Cost-effectiveness of single, high-dose, liposomal amphotericin regimen for HIV-associated cryptococcal meningitis in five countries in sub-Saharan Africa : an economic analysis of the AMBITION-cm trial

enthalten in: The Lancet. Global health | 2022

von Lawrence, D. | Muthoga, C. | Meya, D. | +133

CommentIn: Lancet Glob Health. 2022 Dec;10(12):e1688. - PMID 36400070

2

Xpert Ultra testing of blood in severe HIV-associated tuberculosis to detect and measure Mycobacterium tuberculosis blood stream infection : a diagnostic and disease biomarker cohort study

enthalten in: The Lancet. Microbe | 2022

von Boloko, L. | Schutz, C. | Sibiya, N. | +9

CommentIn: EBioMedicine. 2022 Dec;86:104348. - PMID 36470830

3

Outcomes of laboratory-confirmed SARS-CoV-2 infection during resurgence driven by Omicron lineages BA.4 and BA.5 compared with previous waves in the Western Cape Province, South Africa

enthalten in: medRxiv : the preprint server for health sciences | 2022

von Davies, M. | Morden, E. | Rosseau, P. | +45

UpdateIn: Int J Infect Dis. 2022 Nov 24;127:63-68. - PMID 36436752

4

Outcomes of laboratory-confirmed SARS-CoV-2 infection in the Omicron-driven fourth wave compared with previous waves in the Western Cape Province, South Africa

enthalten in: Tropical medicine & international health : TM & IH | 2022

von Davies, M. | Kassanjee, R. | Rousseau, P. | +44

UpdateOf: medRxiv. 2022 Jan 12;:. - PMID 35043121

5

Clinical features and outcomes of COVID-19 admissions in a population with a high prevalence of HIV and tuberculosis : a multicentre cohort study

enthalten in: BMC infectious diseases | 2022

von Parker, A. | Boloko, L. | Moolla, M. | +29

6

Clinical features and outcomes of COVID-19 admissions in a population with a high prevalence of HIV and tuberculosis: a multicentre cohort study

enthalten in: BMC infectious diseases | 2022

von Parker, A. | Boloko, L. | Moolla, M. | +29

7

Clinical features and outcomes of COVID-19 admissions in a population with a high prevalence of HIV and tuberculosis: a multicentre cohort study

enthalten in: BMC infectious diseases | 2022

von Parker, A. | Boloko, L. | Moolla, M. | +29

8

Outcomes of laboratory-confirmed SARS-CoV-2 infection in the Omicron-driven fourth wave compared with previous waves in the Western Cape Province, South Africa

enthalten in: bioRxiv.org | 2022

von Davies, M. | Kassanjee, R. | Rousseau, P. | +43

9

Assessing the clinical severity of the Omicron variant in the Western Cape Province, South Africa, using the diagnostic PCR proxy marker of RdRp target delay to distinguish between Omicron and Delta infections – a survival analysis

enthalten in: bioRxiv.org | 2022

von Hussey, H. | Davies, M. | Heekes, A. | +24

10

Assessing the clinical severity of the Omicron variant in the Western Cape Province, South Africa, using the diagnostic PCR proxy marker of RdRp target delay to distinguish between Omicron and Delta infections - a survival analysis

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2022

von Hussey, H. | Davies, M. | Heekes, A. | +23